Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost
.03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is
a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the
Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will
be day 270 period.